Roche Diagnostics Corp. FDA Record
- Latest inspection VAI · Aug 1, 2025
- 1 Class I recall
- No warning letters matched by name
Roche Diagnostics Corp. has 39 FDA recalls (1 Class I), 24 inspections, 465 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Roche Diagnostics Corp." is on file.
- Latest recall
- Z-2951-2026 · Jun 10, 2026 · filed under Foundation Medicine
- Latest recall under this name
- Z-1979-2019 · Class II · Jun 3, 2019
- Latest inspection
- Aug 1, 2025 · VAI
- Latest 510(k)
- Oct 20, 2026
Newer recall under related name Foundation Medicine: Jun 10, 2026, Z-2951-2026.
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 39 (1 Class I) | Drug: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Device: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Food: Nov 22, 2026 | Drug: File dated Nov 19, 2026; Device: File dated Nov 19, 2026; Food: File dated Nov 19, 2026 | Current |
| 510(k) clearances | 465 | Nov 22, 2026 | File dated Nov 18, 2026 | Current |
| Inspections | 24 | Nov 22, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 0 | Nov 22, 2026 | Newest record Nov 13, 2026 | Current |
FDA record by year
Roche Diagnostics Corp.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 2 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 1 | 0 | 0 | 0 | 0 |
| 2020 | 1 | 0 | 0 | 0 | 0 |
| 2019 | 1 | 0 | 0 | 6 | 0 |
| 2018 | 2 | 0 | 0 | 17 | 1 |
| 2017 | 0 | 0 | 0 | 15 | 0 |
Reviewing Roche Diagnostics Corp. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Roche Diagnostics Corp. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| Z-1979-2019 | Class II | The Tina-quant lgA Gen.2 is an immunoturbidimetric assay. Anti-lgA antibodies react with antigen in… | Jun 3, 2019 |
| Z-1927-2019 | Class III | cobas p 501 post-analytical units, Part Number 05158494001. For diagnostic sample storage and… | Apr 4, 2019 |
| Z-1928-2019 | Class III | cobas p 701 post-analytical units, Part Number 05349966001. For diagnostic sample storage and… | Apr 4, 2019 |
| Z-1194-2019 | Class II | Albumin BCP Product Usage: ALBP is an in vitro test used for the quantitative determination of… | Mar 18, 2019 |
| Z-1249-2019 | Class II | cobas e 801 immunoassay analyzer | Mar 15, 2019 |
| Z-1368-2019 | Class II | Cobas¿ infinity central lab IT solution Material Number: 07154003001 Calculator/Data… | Feb 4, 2019 |
| Z-1145-2019 | Class II | Bilirubin Total Gen.3, Cat. Nos. 05795397190, 05795419190, 05795320160, 05795338160, 05795346160… | Dec 17, 2018 |
| Z-1146-2019 | Class II | Lactate Gen.2, Catalog Nos. 03183700190, 05171881190, 11822837190, ***added as of 5/10/19***… | Dec 17, 2018 |
| Z-0784-2019 | Class II | Anti-HAV IgM test System, Material No. 11820591160 Product Usage: The Roche Elecsys Anti-HAV IgM… | Dec 17, 2018 |
| Z-1147-2019 | Class II | Tina-quant IgM Gen.2, Catalog Nos. 03507190190, 05220726190, 03507041190, 03507149190 Product… | Dec 17, 2018 |
| Z-1124-2019 | Class II | COBAS INTEGRA 400 plus analyzer used in the following assays: a)Tina-quant Apolipoprotein A-1 ver.2… | Dec 14, 2018 |
| Z-1125-2019 | Class II | cobas c 111 with ISE analyzers analyzer used in the following assays: a)Creatinine plus ver.2… | Dec 14, 2018 |
| Z-0301-2019 | Class II | Roche Diagnostics URISYS 1100 Urine Analyzer Part Number: 03617556001 Product Usage: The URISYS… | Sep 24, 2018 |
| Z-0360-2019 | Class I | CoaguChek¿ XS System Prothrombin time test: CoaguChek XS PT Test 2X24 Strips, Catalog Number… | Sep 13, 2018 |
| Z-2944-2018 | Class II | Roche cobas p 612 pre-analytical system (63x) Model: 07563116001 The cobas p 612 pre-analytical… | Jul 16, 2018 |
| Z-2389-2018 | Class II | Elecsys Vitamin D total II, Vitamin D Test System, Material number 07028148190 Product Usage… | Apr 27, 2018 |
| Z-2390-2018 | Class II | Elecsys Vitamin D total II, Vitamin D Test System, Material number 07464215160 Product Usage… | Apr 27, 2018 |
| Z-2136-2018 | Class II | cobas e 801 immunoassay analyzer, cobas 8000 Modular Series The device is a fully automated… | Apr 3, 2018 |
| Z-1613-2018 | Class II | cobas b 221 AutoQC Module Complete; Catalog numbers: 3313522001 and 3313522692 The Roche… | Feb 22, 2018 |
| Z-1611-2018 | Class II | Cobas b 221<4>Roche OMNI S4 system; Catalog numbers: 3337138001 and 3337138692 The Roche… | Feb 22, 2018 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Aug 1, 2025 | Penzberg, Germany | Biologics | Voluntary Action Indicated (VAI) | 3002806560 |
| May 22, 2025 | Penzberg, Germany | Drugs | Voluntary Action Indicated (VAI) | 3002806560 |
| Oct 29, 2021 | Mannheim, Germany | Drugs | Voluntary Action Indicated (VAI) | 3002806559 |
| Sep 16, 2020 | Penzberg, Germany | Drugs | Voluntary Action Indicated (VAI) | 3002806560 |
| Aug 29, 2019 | Mannheim, Germany | Devices | Voluntary Action Indicated (VAI) | 3002806559 |
| Apr 19, 2018 | Mannheim, Germany | Devices | No Action Indicated (NAI) | 3002806559 |
| Apr 12, 2018 | Penzberg, Germany | Devices | No Action Indicated (NAI) | 3002806560 |
| Nov 18, 2016 | Mannheim, Germany | Devices | No Action Indicated (NAI) | 3002806559 |
| Apr 29, 2016 | Penzberg, Germany | Drugs | Voluntary Action Indicated (VAI) | 3002806560 |
| Apr 22, 2016 | Mannheim, Germany | Drugs | No Action Indicated (NAI) | 3002806559 |
| May 27, 2015 | Mannheim, Germany | Devices | No Action Indicated (NAI) | 3002806559 |
| May 20, 2015 | Penzberg, Germany | Devices | No Action Indicated (NAI) | 3002806560 |
| May 16, 2014 | Penzberg, Germany | Drugs | Voluntary Action Indicated (VAI) | 3002806560 |
| Apr 4, 2014 | Mannheim, Germany | Drugs | Voluntary Action Indicated (VAI) | 3002806559 |
| Dec 18, 2013 | Mannheim, Germany | Devices | No Action Indicated (NAI) | 3002806559 |
| Oct 16, 2012 | Penzberg, Germany | Drugs | Voluntary Action Indicated (VAI) | 3002806560 |
| Sep 27, 2012 | Mannheim, Germany | Devices | No Action Indicated (NAI) | 3002806559 |
| Sep 20, 2012 | Penzberg, Germany | Devices | No Action Indicated (NAI) | 3002806560 |
| Apr 26, 2012 | Mannheim, Germany | Drugs | Voluntary Action Indicated (VAI) | 3002806559 |
| Feb 17, 2011 | Mannheim, Germany | Devices | No Action Indicated (NAI) | 3002806559 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3002806560 | Penzberg, Germany | 11 | Aug 1, 2025 |
| FEI 3002806559 | Mannheim, Germany | 13 | Oct 29, 2021 |
Recent 510(k) clearances
| K-Number | Device | Date |
|---|---|---|
| DEN260027 | Elecsys HBsAg II quant II RxDx | Oct 20, 2026 |
| K260233 | Elecsys EBV IgM | Oct 2, 2026 |
| K260221 | Elecsys EBV EBNA IgG | Oct 2, 2026 |
| K260232 | Elecsys EBV VCA IgG | Oct 2, 2026 |
| K261686 | Elecsys Phospho-Tau (217P) Plasma | Aug 19, 2026 |
| K252323 | cobas pulse blood glucose monitoring system | Jun 12, 2026 |
| K252431 | Elecsys Calcitonin | Apr 24, 2026 |
| K252280 | Elecsys Anti-SARS-CoV-2 S | Apr 13, 2026 |
| K260046 | Elecsys Anti-HBc II | Apr 7, 2026 |
| K260048 | Elecsys Anti-HAV IgM | Apr 7, 2026 |
| K260049 | Elecsys Anti-HBc IgM | Apr 7, 2026 |
| K260026 | Tina-quant Cardiac high sensitivity CRP III | Apr 2, 2026 |
| K253490 | Glucose HK Gen.3; ONLINE DAT Methadone II; cobas pro integrated solutions | Feb 12, 2026 |
| K253491 | ISE indirect K for Gen.2; ISE indirect Na for Gen.2; ISE indirect Cl for Gen.2; cobas pro integrated… | Feb 12, 2026 |
| K253839 | Elecsys Anti-SARS-CoV-2 | Dec 17, 2025 |
| K253188 | CoaguChek XS Plus System | Oct 24, 2025 |
| K252163 | Elecsys Phospho-Tau (181P) Plasma | Oct 8, 2025 |
| K242505 | Elecsys Cortisol III | Jul 17, 2025 |
| K250768 | Elecsys Anti-SARS-CoV-2 | Jun 10, 2025 |
| K241453 | Elecsys sFlt-1 and Elecsys PlGF | Feb 7, 2025 |
Roche Diagnostics Corp. and the FDA: common questions
Has Roche Diagnostics Corp. received an FDA warning letter?
No FDA warning letter addressed to the name "Roche Diagnostics Corp." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Roche Diagnostics Corp. received an FDA Form 483?
FDA has not published a Form 483 for "Roche Diagnostics Corp." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Roche Diagnostics Corp.?
The most recent FDA inspection on file ended Aug 1, 2025 at Penzberg, Germany and was classified VAI. FDA has 24 inspections of Roche Diagnostics Corp. on file.
Has Roche Diagnostics Corp. had an FDA recall?
Yes. Roche Diagnostics Corp. has 39 FDA recalls on record, 1 of them Class I, the most serious class. The most recent under this name started Jun 3, 2019. A newer recall, dated Jun 10, 2026, is filed under the related name Foundation Medicine.
Need more than this page shows? Ask about Roche Diagnostics Corp. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.